Capital World Investors Eli Lilly & CO Transaction History

Capital World Investors

$625 Billion
Q3 2024

A detailed history of Capital World Investors transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital World Investors holds 20,355,946 shares of LLY stock, worth $16.2 Billion. This represents 2.88% of its overall portfolio holdings.

Number of Shares

20,355,946

Previous 21,813,763 6.68%

Holding current value

$16.2 Billion

Previous $19.7 Billion 8.69%

% of portfolio

2.88%

Previous 3.31%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $1.13 Billion - $1.4 Billion	-1,457,817 Reduced 6.68%	20,355,946 $18 Billion
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $1.97 Billion - $2.47 Billion	-2,722,292 Reduced 11.1%	21,813,763 $19.7 Billion
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $1.43 Billion - $1.91 Billion	-2,413,718 Reduced 8.96%	24,536,055 $19.1 Billion
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $47.1 Million - $55.5 Million	89,720 Added 0.33%	26,949,773 $15.7 Billion
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $3.27 Million - $4.51 Million	-7,528 Reduced 0.03%	26,860,053 $14.4 Billion
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $253 Million - $338 Million	-720,959 Reduced 2.61%	26,867,581 $12.6 Billion
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $186 Million - $219 Million	-599,899 Reduced 2.13%	27,588,540 $9.47 Billion
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $269 Million - $313 Million	-836,435 Reduced 2.88%	28,188,439 $10.3 Billion
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $83.7 Million - $95.4 Million	282,228 Added 0.98%	29,024,874 $9.39 Billion
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.78 Billion - $2.09 Billion	6,384,202 Added 28.55%	28,742,646 $9.32 Billion
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $761 Million - $946 Million	3,242,548 Added 16.96%	22,358,444 $6.4 Billion
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $523 Million - $649 Million	2,325,514 Added 13.85%	19,115,896 $5.28 Billion
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $333 Million - $410 Million	1,502,363 Added 9.83%	16,790,382 $3.88 Billion
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $123 Million - $160 Million	683,842 Added 4.68%	15,288,019 $3.51 Billion
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $1.93 Billion - $2.5 Billion	11,750,226 Added 411.72%	14,604,177 $2.73 Billion
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $29.3 Million - $38.7 Million	-224,418 Reduced 7.29%	2,853,951 $482 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $65,067 - $75,262	445 Added 0.01%	3,078,369 $456 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $5.88 Million - $7.07 Million	43,075 Added 1.42%	3,077,924 $505 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $203 Million - $251 Million	1,706,354 Added 128.44%	3,034,849 $421 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $1.26 Million - $1.56 Million	-11,769 Reduced 0.88%	1,328,495 $175 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $13.9 Million - $15.1 Million	-129,783 Reduced 8.83%	1,340,264 $150 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $6.45 Million - $7.53 Million	58,247 Added 4.13%	1,470,047 $163 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $42.2 Million - $47.3 Million	398,500 Added 39.33%	1,411,800 $163 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $55.7 Million - $69.6 Million	648,300 Added 177.62%	1,013,300 $109 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $11.4 Million - $13 Million	150,000 Added 69.77%	365,000 $31.1 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $17.6 Million - $18.9 Million	215,000	215,000 $18.2 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Eli Lilly & CO Transaction History